PRIZES to win! PROMOTIONS

Close Notification

Your cart does not contain any items

$363.95

Paperback

Not in-store but you can order this
How long will it take?

QTY:

English
Academic Press Inc
07 November 2025
Diabetes and Alzheimer's Disease: Mechanisms and Management delves into the complex relationship between diabetes and Alzheimer’s disease. The book examines how these conditions intersect and influence each other, providing insights into their pathophysiological and epidemiological aspects. Readers will gain a thorough understanding of metabolic interactions, molecular signaling, and various factors that regulate the confluence of these diseases. Written by experts, this comprehensive guide is essential for researchers, academicians, scientists, and graduate students in biomedical and pharmaceutical sciences. In addition to exploring the mechanisms, the book discusses theranostics and strategies to manage both conditions.

It includes sections on drug repositioning, dietary modifications, and the impact of metabolic dysfunction on neurological disorders.
Edited by:   , , , , , ,
Imprint:   Academic Press Inc
Country of Publication:   United States
Dimensions:   Height: 235mm,  Width: 191mm, 
Weight:   450g
ISBN:   9780443405594
ISBN 10:   044340559X
Pages:   402
Publication Date:  
Audience:   Professional and scholarly ,  Undergraduate
Format:   Paperback
Publisher's Status:   Active
1. Introduction to Confluence of Diabetes and Alzheimer's Disease 2. Epidemiology related to Diabetes and Alzheimer's Disease 3. Pathophysiology of Diabetes and Alzheimer's Disease 4. Metabolic Relationship and Crosstalk in Diabetes and Alzheimer's Disease 5. Insulin Signaling in Diabetes and Alzheimer's Disease 6. Epigenetic Insight of Alzheimer's Disease and Diabetes 7. Inflammation in Alzheimer's Disease and Diabetes 8. Possible impact of Co-occurrence of Alzheimer's Disease and Diabetes 9. Impact of Oxidative Stress on Diabetes and Alzheimer's Disease 10. Cognitive Dysfunction: Link between Diabetes and Alzheimer's Disease 11. Theronostics in Alzheimer's Disease and Diabetes 12. Drug Repositioning Strategies of Anti-diabetic Drugs for Alzheimer's Disease 13. Nutritional Aspect and Management of Alzheimer's Disease and Diabetes

Dr. Awanish Kumar is currently an Associate Professor and Head of the Department of Biotechnology at the National Institute of Technology, Raipur (CG), India. He has more than 16 years of research experience. He received his PhD in Biotechnology from the CSIR-Central Drug Research Institute, Lucknow, India, and Jawaharlal Nehru University, Delhi, India, and completed his postdoctoral studies at McGill University, Montreal, Canada. His research interests are infection biology, drug targeting, and drug discovery. He has served on various national and international organizations in different academic and research capacities. He has also served on many national committees and scientific advisory panels, as a member of many international professional research societies, and as a reviewer and editorial board member of reputed and refereed journals. He has authored or edited several monographs, books, and book chapters. Dr. T.R. Anju is currently an Assistant Professor in biotechnology at Newman College, Kerala, India, and Secretary of Society for Biotechnologists, India. She completed her Master’s degree in biotechnology at Gulbarga University, Karnataka, India and doctoral degree at the Centre for Neuroscience, Cochin University of Science and Technology, Kochi, India. She completed her postdoctoral research on a 5-year project funded by the Department of Biotechnology to study the long-term effects of neonatal hypoglycemia. She has published 48 research papers in SCI journals, 27 book chapters, and edited 7 books and is the recipient of the Kerala State Young Scientist Award 2012 by the Kerala State Council for Science, Technology and Environment, and various other awards. Her research is focused on molecular signaling and neurotransmitter receptor functions in the brain under neonatal stress and various disease conditions like diabetes and epilepsy. Currently, her research team is working on nanotechnology and phytoconstituent-based interventions for biomedical applications.

See Also